Results 241 to 250 of about 64,747 (267)
Some of the next articles are maybe not open access.
Casopis lekaru ceskych, 1996
The paclitaxel (TAXOL); Bristol-Myers Squibb Company) represents first agent from novel class of antineoplastic drugs--taxanes to enter routine clinical practice. Paclitaxel interferes with microtubular polymerization by promoting abnormal assembly of microtubules and inhibiting their subsequent disassembly.
openaire +1 more source
The paclitaxel (TAXOL); Bristol-Myers Squibb Company) represents first agent from novel class of antineoplastic drugs--taxanes to enter routine clinical practice. Paclitaxel interferes with microtubular polymerization by promoting abnormal assembly of microtubules and inhibiting their subsequent disassembly.
openaire +1 more source
Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains
European Journal of Medicinal Chemistry, 2019Syed Shafi, M Shahar Yar
exaly
Taxol®: The First Microtubule Stabilizing Agent
International Journal of Molecular Sciences, 2017Chia-Ping Huang Yang
exaly
Mechanisms of Taxol resistance related to microtubules
Oncogene, 2003Pascal Verdier-Pinard, Hayley M Mcdaid
exaly